1. Clinical efficacy of a new CD28‐targeting antagonist of T cell co‐stimulation in a non‐human primate model of collagen‐induced arthritis. (16th December 2015) Authors: Vierboom, M. P. M.; Breedveld, E.; Kap, Y. S.; Mary, C.; Poirier, N.; 't Hart, B. A.; Vanhove, B. Journal: Clinical and experimental immunology Issue: Volume 183:Number 3(2016:Mar.) Page Start: 405 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Immune modulation by a tolerogenic myelin oligodendrocyte glycoprotein (MOG)10–60 containing fusion protein in the marmoset experimental autoimmune encephalomyelitis model. (April 2015) Authors: Kap, Y. S.; van Driel, N.; Arends, R.; Rouwendal, G.; Verolin, M.; Blezer, E.; Lycke, N.; 't Hart, B. A. Journal: Clinical and experimental immunology Issue: Volume 180:Number 1(2015:Apr.) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Whole blood stimulation with Toll‐like receptor (TLR)‐7/8 and TLR‐9 agonists induces interleukin‐12p40 expression in plasmacytoid dendritic cells in rhesus macaques but not in humans. (8th September 2013) Authors: Koopman, G.; Beenhakker, N.; Burm, S.; Bouwhuis, O.; Bajramovic, J.; Sommandas, V.; Mudde, G.; Mooij, P.; 't Hart, B. A.; Bogers, W. M. J. M. Journal: Clinical and experimental immunology Issue: Volume 174:Number 1(2013:Oct.) Page Start: 161 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗